Fig. 3From: Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysisForest plot of the sensitivity and specificity of MR-proADM to predict mortality in CAP. The pooled sensitivity and specificity were 0.74 (95 % CI: 0.67–0.79) and 0.73 (95 % CI: 0.70–0.77), respectivelyBack to article page